Link between erythropoietin release and mobilization of endothelial progenitor cells in acute myocardial infarction

European Heart Journal

Volumn 28, Issue 15, 2007, Pages 1785-1786

  Wojakowski, Wojciech ^a   Kazmierski, MacIej ^a   Korzeniowska, Barbara ^a   Tendera, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ENDOTHELIUM; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; TIME FACTORS;

EID: 34547747349     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm260     Document Type: Editorial

References (15)

1. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353.
2. Wojakowski W, Tendera M. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 2005;43: 229-232.
3. Ferrario M, Massa M, Rosti V, Campanelli R, Ferlini M, Marinoni B, De Ferrari GM, Meli V, De Amici M, Repetto A, Verri A, Bramucci E, Tavazzi L. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J 2007;28:1805-1813. First published on April 5, 2007, doi: 10.1093/eurheartj/ehm065.
4. Massa M et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
5. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006;10:318-332.
6. Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G, Guelly C, Strunk D. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006;24:357-367.
7. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531.
8. Wojakowski W et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213-3220.
9. Wojakowski W, Kucia M, Kazmierski M, Ratajczak MZ, Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes - relevant reparatory mechanism? Heart 2007; published online, doi:10.1136/ht.2006.103358.
10. Fazel S, Chimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877.
11. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams L, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95: 952-958.
12. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-3427.
13. Nakul-Aquaronne D, Bayle J, Frelin C. Coexpression of endothelial markers and CD14 by cytokine mobilized CD34(+) cells under angiogenic stimulation. Cardiovasc Res 2003;57:816-823.
14. Kucia M et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006;20:857-869.
15. Inoue T et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation impact on restenosis. Circulation 2007;115:553-561.